家 » 全部 » 库存预测 » Atrium Therapeutics Inc. Common Stock 预报

Atrium Therapeutics Inc. Common Stock 预报: 明天, 下周, 下个月, 5年

已更新: April 22 · 2026 at 07:03 UTC

From

▼ -5.38%Market Cap $2.10B · Technical analysis Bearish · Focus area Price + volatility

预测总结

大体时间	预计价格	过去的	历史	洞察力
明天	$13.76 ▲ +1.68%	昨天	$13.43 ▼ -0.71%	Tomorrow's Atrium Therapeutics Inc. Common Stock (RNA) setup is anchored to $13.53 and targets $13.76 (+1.68%). The near-term read is upside; watch $13.94 / $13.12 because daily realized volatility is about 8.00%.
Tomorrow's Atrium Therapeutics Inc. Common Stock (RNA) setup is anchored to $13.53 and targets $13.76 (+1.68%). The near-term read is upside; watch $13.94 / $13.12 because daily realized volatility is about 8.00%.
下周	$14.24 ▲ +5.23%	上星期	$13.23 ▼ -2.19%	The 7-day Atrium Therapeutics Inc. Common Stock model moves from $13.23 to $14.24 (+5.23%). It gives upside momentum context for this stock, so breaks around $13.94 / $13.12 matter more than a single tick.
The 7-day Atrium Therapeutics Inc. Common Stock model moves from $13.23 to $14.24 (+5.23%). It gives upside momentum context for this stock, so breaks around $13.94 / $13.12 matter more than a single tick.
下个月	$15.04 ▲ +11.13%	上个月	$12.90 ▼ -4.67%	The 1-month Atrium Therapeutics Inc. Common Stock target is $15.04 (+11.13%), compared with the live reference near $13.53. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Atrium Therapeutics Inc. Common Stock target is $15.04 (+11.13%), compared with the live reference near $13.53. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
明年	$16.23 ▲ +19.98%	去年	$12.39 ▼ -8.39%	The 1-year Atrium Therapeutics Inc. Common Stock scenario points to $16.23 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Atrium Therapeutics Inc. Common Stock scenario points to $16.23 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年	$19.04 ▲ +40.71%	5年前	$11.22 ▼ -17.10%	The 5-year Atrium Therapeutics Inc. Common Stock view is $19.04 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Atrium Therapeutics Inc. Common Stock view is $19.04 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

明天$13.76▲ +1.68%

昨天$13.43▼ -0.71%

Tomorrow's Atrium Therapeutics Inc. Common Stock (RNA) setup is anchored to $13.53 and targets $13.76 (+1.68%). The near-term read is upside; watch $13.94 / $13.12 because daily realized volatility is about 8.00%.

下周$14.24▲ +5.23%

上星期$13.23▼ -2.19%

The 7-day Atrium Therapeutics Inc. Common Stock model moves from $13.23 to $14.24 (+5.23%). It gives upside momentum context for this stock, so breaks around $13.94 / $13.12 matter more than a single tick.

下个月$15.04▲ +11.13%

上个月$12.90▼ -4.67%

The 1-month Atrium Therapeutics Inc. Common Stock target is $15.04 (+11.13%), compared with the live reference near $13.53. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

明年$16.23▲ +19.98%

去年$12.39▼ -8.39%

The 1-year Atrium Therapeutics Inc. Common Stock scenario points to $16.23 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5年$19.04▲ +40.71%

5年前$11.22▼ -17.10%

The 5-year Atrium Therapeutics Inc. Common Stock view is $19.04 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

价格走势图

历史预报看涨看跌

技术分析

Neutral

看涨

中性的

看跌

关键指标

指标	价值	信号
Price	$13.53	Mid
Daily Change	-5.38%	Below
Volatility Cap	20.0%	Mid
Confidence	69%	Above
Data Source	nasdaq-screener	Mid

史料

Current$13.53

Daily Change-5.38%

Market Cap$2.10B

Sourcenasdaq-screener

Current	$13.53	Daily Change	-5.38%
Market Cap	$2.10B	Source	nasdaq-screener

支撑位和阻力位

$13.12Support 1

$13.53当前

$13.94Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

价格里程碑

关键层面和历史背景

Current$13.53Live reference price

Used as the anchor for generated forecast calculations.

Next Month$15.04Model projection+11.13%

Directional scenario based on capped drift.

预测准确度

我们的模型表现如何

69%

定向

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

我们的算法每周使用最新的价格行为、波动机制和指标信号进行重新校准。准确性因时间范围而异——短期势头比长期预测更可靠。

Short term

69%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

投资场景

如果您今天投资 $1,000 于 RNA

Bullish Scenario

$14.21

+5.00% from current

目标价格$14.21

设想Upside momentum

可能性61%

Base Scenario

$15.04

+11.13%

目标价格$15.04

设想Capped drift

可能性69%

Bearish Scenario

$12.85

-5.00% from current

目标价格$12.85

设想Volatility drawdown

可能性31%

基础: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

预测因素

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 74/100

24H drift+1.68%

7D drift+5.23%

30D drift+11.13%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 70/100

1M outlook+11.13%

1Y outlook+19.98%

5Y outlook+40.71%

常见问题解答

Q What is the Atrium Therapeutics Inc. Common Stock (RNA) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Atrium Therapeutics Inc. Common Stock is projected near $13.76 versus the current reference around $13.53. That implies a modeled move of +1.68% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for RNA?

The weekly Atrium Therapeutics Inc. Common Stock model points to $14.24, which maps to an expected drift of +5.23% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Atrium Therapeutics Inc. Common Stock 1-month and 1-year targets?

The Atrium Therapeutics Inc. Common Stock 1-month target is $15.04 (+11.13%), while the 1-year target is $16.23 (+19.98%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Atrium Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The Atrium Therapeutics Inc. Common Stock long-horizon scenario sits near $19.04 with a modeled change of +40.71%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are RNA support and resistance zones right now?

For Atrium Therapeutics Inc. Common Stock, nearest resistance is around $13.12, while nearest support is around $13.94. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Atrium Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.